US 11034672
Tyrosine kinase inhibitor compositions, methods of making and methods of use
granted A61PA61P35/00
Quick answer
US patent 11034672 (Tyrosine kinase inhibitor compositions, methods of making and methods of use) held by Black Diamond Therapeutics, Inc. expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Black Diamond Therapeutics, Inc.
- Grant date
- Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61P, A61P35/00